Search details
1.
Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives.
Jpn J Clin Oncol
; 54(3): 265-270, 2024 Mar 09.
Article
in English
| MEDLINE | ID: mdl-38117955
2.
Pharmacokinetic and dose-finding study of osimertinib in patients with impaired renal function and low body weight.
Cancer Sci
; 114(5): 2087-2097, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36704833
3.
Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.
Br J Cancer
; 129(12): 2003-2013, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37731022
4.
Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations.
Cancer Immunol Immunother
; 72(8): 2613-2621, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37062033
5.
Comparison of time to failure of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy: a consecutive analysis of patients having NSCLC with high PD-L1 expression.
Cancer Immunol Immunother
; 71(3): 737-746, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-34389874
6.
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab.
Cancer Immunol Immunother
; 71(2): 387-398, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34180007
7.
Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.
Eur J Clin Pharmacol
; 78(4): 613-621, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35039908
8.
Performance of Japanese patients in registrational studies.
Jpn J Clin Oncol
; 52(1): 53-64, 2022 Jan 03.
Article
in English
| MEDLINE | ID: mdl-34978326
9.
Development of an optimal protocol for molecular profiling of tumor cells in pleural effusions at single-cell level.
Cancer Sci
; 112(5): 2006-2019, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33484069
10.
Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.
Cancer Sci
; 112(10): 4393-4403, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34310819
11.
Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment.
Br J Cancer
; 124(5): 925-932, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33250511
12.
Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.
Jpn J Clin Oncol
; 51(7): 1114-1122, 2021 Jul 01.
Article
in English
| MEDLINE | ID: mdl-33881137
13.
Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.
Cancer Immunol Immunother
; 69(7): 1229-1236, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32152703
14.
Toward Efficient Synthesis of Chiral Zeolites: A Rational Strategy for Fluoride-Free Synthesis of STW-Type Zeolite.
Angew Chem Int Ed Engl
; 59(45): 20099-20103, 2020 11 02.
Article
in English
| MEDLINE | ID: mdl-32720465
15.
Correction: Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.
Br J Cancer
; 129(12): 2034, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37923915
16.
Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talc.
Respirology
; 23(1): 55-59, 2018 01.
Article
in English
| MEDLINE | ID: mdl-28980363
17.
[The nutritional and dietary intake among community-dwelling elderly female users of mobile vendor vehicles].
Nihon Ronen Igakkai Zasshi
; 55(1): 51-64, 2018.
Article
in Japanese
| MEDLINE | ID: mdl-29503369
18.
Corrigendum to: Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.
Jpn J Clin Oncol
; 51(7): 1183, 2021 Jul 01.
Article
in English
| MEDLINE | ID: mdl-34100088
19.
Efficacy and safety of chemoimmunotherapy in advanced non-small cell lung cancer patients with antibiotics-induced dysbiosis: a propensity-matched real-world analysis.
J Cancer Res Clin Oncol
; 150(4): 216, 2024 Apr 26.
Article
in English
| MEDLINE | ID: mdl-38668936
20.
Distinct Progression and Efficacy of First-Line Osimertinib Treatment According to Mutation Subtypes in Metastatic NSCLC Harboring EGFR Mutations.
JTO Clin Res Rep
; 5(2): 100636, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38361742